Inst Diagnosti (INDISA) - Total Liabilities

Latest as of June 2025: CL$191.22 Billion CLP ≈ $213.85 Million USD

Based on the latest financial reports, Inst Diagnosti (INDISA) has total liabilities worth CL$191.22 Billion CLP (≈ $213.85 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Inst Diagnosti - Total Liabilities Trend (2014–2025)

This chart illustrates how Inst Diagnosti's total liabilities have evolved over time, based on quarterly financial data. See INDISA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Inst Diagnosti Competitors by Total Liabilities

The table below lists competitors of Inst Diagnosti ranked by their total liabilities.

Company Country Total Liabilities
DINGDONG CAYMAN 2ADR/3 A
F:945
Germany €5.84 Billion
The Metals Royalty Company Inc. Common Stock
NASDAQ:TMCR
USA $1.76 Million
Digi Communications NV
RO:DIGI
Romania RON3.11 Billion
Hunan Kylinsec Technology Co. Ltd. A
SHG:688152
China CN¥169.71 Million
Jiangyin Pivot Automotive Products Co. Ltd.
SHE:301181
China CN¥215.50 Million
ProCredit Holding AG & Co KGaA
XETRA:PCZ
Germany €10.01 Billion
Laxmi Organic Industries Limited
NSE:LXCHEM
India Rs12.67 Billion
Krishana Phoschem Limited
NSE:KRISHANA
India Rs10.80 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Inst Diagnosti's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Inst Diagnosti.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.00 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.68 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.63 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Inst Diagnosti's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Inst Diagnosti (2014–2025)

The table below shows the annual total liabilities of Inst Diagnosti from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 CL$201.84 Billion
≈ $225.72 Million
+23.61%
2024-12-31 CL$163.28 Billion
≈ $182.60 Million
-5.38%
2023-12-31 CL$172.56 Billion
≈ $192.98 Million
+0.75%
2022-12-31 CL$171.26 Billion
≈ $191.53 Million
+26.20%
2021-12-31 CL$135.71 Billion
≈ $151.77 Million
+38.62%
2020-12-31 CL$97.90 Billion
≈ $109.49 Million
+13.08%
2019-12-31 CL$86.58 Billion
≈ $96.82 Million
-0.96%
2018-12-31 CL$87.42 Billion
≈ $97.76 Million
-3.79%
2017-12-31 CL$90.86 Billion
≈ $101.61 Million
-0.33%
2016-12-31 CL$91.16 Billion
≈ $101.95 Million
+15.85%
2015-12-31 CL$78.69 Billion
≈ $88.00 Million
+27.89%
2014-12-31 CL$61.53 Billion
≈ $68.81 Million
--

About Inst Diagnosti

SN:INDISA Chile Medical Care Facilities
Market Cap
$459.61 Million
CL$410.98 Billion CLP
Market Cap Rank
#12869 Global
#55 in Chile
Share Price
CL$2678.60
Change (1 day)
-0.76%
52-Week Range
CL$2106.10 - CL$2889.90
All Time High
CL$2889.90
About

Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hos… Read more